J.P. Morgan Expects Agilent Analyst Meeting To Be A Positive Catalyst Owing To Updates On New Product Traction

In a report published by J.P. Morgan, Agilent's

analyst meeting should be a positive catalyst owing to updates on new product traction. J.P. Morgan reported that the Overweight-rated Agilent is set to host its analyst meeting in New York on March 3. “We expect the investor meeting to be a positive event for Agilent's stock and the broader T&M market. Sustainability of mega-trends in both electronic test and life science tools stands to be a focal point. We also expect updates on 1) the potential of further operating leverage, 2) the sustainability of current revenue growth trends, and 3) capital management. Pittcon (March 14-16) stands to be the next catalyst, with potential for the company to launch a new LC (and perhaps mass spec) products.” Agilent closed yesterday at $40.68.